TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2295223

Group type: EXPERIMENTAL
Intervention: Oral melphalan (0.25 mg/kg) alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral melphalan (0.25 mg/kg) after interferon (7 x 10(6) IU/m2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Interferon administration
Number of subjects: 10
Study: 31358085

Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28406394

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg/day)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Prednisolone (0.5 mg/kg/day)
Number of subjects: 253
Study: 26656280

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) 3 times a week for 16 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 24
Study: 25331030

Group type: EXPERIMENTAL
Intervention: Ipamorelin 0.03 mg/kg intravenous infusion twice daily
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Ipamorelin
Number of subjects: 117
Study: 21863263

Group type: EXPERIMENTAL
Intervention: Octreotide long-acting release (OCT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lanreotide Autogel (LAN)
Number of subjects: 68
Study: 19887796

Group type: EXPERIMENTAL
Intervention: Oral rapamycin (4 mg loading dose followed by 2 mg daily for 30 days)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Oral rapamycin
Number of subjects: 108
Study: 17394729

Group type: EXPERIMENTAL
Intervention: Living alone
Number of subjects: 2641
Study: 15680531

Group type: EXPERIMENTAL
Intervention: Two handed chest compression
Number of subjects: 30

Group type: COMPARATOR
Intervention: One handed chest compression
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Two handed technique
Number of subjects: 30
Study: 12111130

Group type: EXPERIMENTAL
Intervention: Limbic system perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hippocampus perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cingulate cortex perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Parahippocampal cortex perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amygdala/entorhinal cortex perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Septal area perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Anterior thalamus perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Posterior cingulate cortex perfusion in AD patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Basal forebrain, hypothalamus, mamillary bodies, orbitofrontal cortex perfusion in AD patients
Number of subjects: 40
Study: 10440971

Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT) for 1 hour per day for 4 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control condition with dim light exposure for 4 weeks
Number of subjects: 15
Study: 7752281

Group type: EXPERIMENTAL
Intervention: 20 mg or 40 mg of lovastatin
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 431
Study: 1982614

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg once daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Azatadine 1 mg twice daily
Number of subjects: 34
Study: 361143

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen
Number of subjects: 241

Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 241
Study: 31352083

Group type: EXPERIMENTAL
Intervention: H2-producing milk
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 27815351

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week from Week 4 to Week 52
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo every other week from Week 4 to Week 52
Number of subjects: 0
Study: 25723494

Group type: EXPERIMENTAL
Intervention: cART
Number of subjects: 22
Study: 23802703

Group type: EXPERIMENTAL
Intervention: Pre-test measurement (12 true/false statements)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: HPV leaflet reading
Number of subjects: 237
Study: 21923647

Group type: EXPERIMENTAL
Intervention: Collaborative condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-frequency words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-frequency words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remember (R) responses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Know (K) responses
Number of subjects: 0
Study: 19338141

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of lamivudine 40 mg and stavudine 10 mg tablet for oral suspension
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual liquid formulations of lamivudine and stavudine
Number of subjects: 0
Study: 17768267

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Mood improvement
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290

Group type: COMPARATOR
Intervention: Non-recovered post-ACS control group
Number of subjects: 290
Study: 15302717

Group type: EXPERIMENTAL
Intervention: HRV biofeedback and abdominal breathing through pursed lips and prolonged exhalation
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: HRV biofeedback alone
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo EEG biofeedback
Number of subjects: 94

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 94
Study: 12184348

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for depression (8 weeks duration)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Established treatments for Major Depression
Number of subjects: 38
Study: 9041569

Group type: EXPERIMENTAL
Intervention: Atropine 20 micrograms.kg-1 i.m.
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Atropine 30 micrograms.kg-1 orally
Number of subjects: 45

Group type: COMPARATOR
Intervention: No atropine (control group)
Number of subjects: 45
Study: 7946257

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 8
Study: 3108921

Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29789410

Group type: EXPERIMENTAL
Intervention: Subcutaneous ATL1103 200 mg twice weekly for 13 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Subcutaneous ATL1103 200 mg once weekly for 13 weeks
Number of subjects: 26
Study: 28264717

Group type: EXPERIMENTAL
Intervention: MOBIGAME smartphone-based game application (24 weeks duration)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard lifestyle counseling (one-time intervention)
Number of subjects: 42
Study: 25310336

Group type: EXPERIMENTAL
Intervention: Gastrocnemius stretching program with STJ positioned in pronation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Gastrocnemius stretching program with STJ positioned in supination
Number of subjects: 22
Study: 24968520

Group type: EXPERIMENTAL
Intervention: letrozole + FSH
Number of subjects: 55

Group type: COMPARATOR
Intervention: only FSH
Number of subjects: 55
Study: 21173006

Group type: EXPERIMENTAL
Intervention: Improved blood pressure monitoring (near-continuous, noninvasive device)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Intermittent blood pressure monitoring (oscillometric device)
Number of subjects: 94
Study: 18355408

Group type: EXPERIMENTAL
Intervention: Second generation PermaNet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First generation PermaNet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventionally treated nets
Number of subjects: 0
Study: 16971717

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent
Number of subjects: 619

Group type: COMPARATOR
Intervention: Uncoated stent
Number of subjects: 619
Study: 15319242

Group type: EXPERIMENTAL
Intervention: docetaxel 40 mg/m2 weekly for 6 consecutive weeks followed by 2 weeks without treatment (n = 41)
Number of subjects: 83

Group type: COMPARATOR
Intervention: docetaxel 100 mg/m2 on day 1 every 3 weeks (n = 42)
Number of subjects: 83
Study: 11545756

Group type: EXPERIMENTAL
Intervention: Dual-site RA pacing with overdrive algorithm
Number of subjects: 22

Group type: COMPARATOR
Intervention: High right atrial pacing at 30 beats/min (Off)
Number of subjects: 22
Study: 15102427

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intracutaneous infiltration with 2% lidocaine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ethyl chloride spray
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 150

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 150
Study: 8218959

Group type: EXPERIMENTAL
Intervention: Disopyramide formulation 1 (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Disopyramide formulation 2 (100 mg)
Number of subjects: 8
Study: 2446757

Group type: EXPERIMENTAL
Intervention: Imunovir
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 28158421

Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffold (BVS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Cobalt chromium metallic stent (CoCr-EES)
Number of subjects: 110
Study: 27245914

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula alone
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard oxygen
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation plus interspaced high-flow nasal cannula
Number of subjects: 82
Study: 25012121

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy, treatment three times a week for 5 weeks.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cupping therapy, treatment three times a week for 5 weeks.
Number of subjects: 100
Study: 22064876

Group type: EXPERIMENTAL
Intervention: Doctor-office collaborative care (DOCC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 78
Study: 20693179

Group type: EXPERIMENTAL
Intervention: Overall Benefit of Analgesia Score (OBAS)
Number of subjects: 1470

Group type: COMPARATOR
Intervention: Pain scores at rest or during movement
Number of subjects: 1470
Study: 18274949

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 50)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Comparison group (n = 66)
Number of subjects: 116
Study: 15868003

Group type: COMPARATOR
Intervention: Pedicled group (PG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Skeletonized group (SG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of SG to PG after topical vasodilator application
Number of subjects: 50
Study: 14506498

Group type: EXPERIMENTAL
Intervention: Diet plus exercise (DE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diet (D)
Number of subjects: 40
Study: 10584722

Group type: EXPERIMENTAL
Intervention: Microwave endometrial ablation (MEA), n=129
Number of subjects: 263

Group type: COMPARATOR
Intervention: Transcervical resection of the endometrium (TCRE), n=134
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Microwave endometrial ablation (MEA)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Transcervical resection of the endometrium (TCRE)
Number of subjects: 263
Study: 8543518

Group type: EXPERIMENTAL
Intervention: Exposure to parental conflict
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Exposure to parental psychopathology
Number of subjects: 140

Group type: COMPARATOR
Intervention: Normal control probands
Number of subjects: 140
Study: 2509916

Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon alfa three times weekly for 24 weeks
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 1 million units of recombinant interferon alfa three times weekly for 24 weeks
Number of subjects: 166

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 3 million units of interferon
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 1 million units of interferon
Number of subjects: 166
Study: 31930627

Group type: EXPERIMENTAL
Intervention: Dissatisfaction with life
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Living without a spouse
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Absence of leisure time activity
Number of subjects: 323
Study: 31567876

Group type: EXPERIMENTAL
Intervention: HALC with high MIAT levels
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: HALC with MIAT level <10.9 in CC tissue or <8.7 in serum
Number of subjects: 320

Group type: COMPARATOR
Intervention: LAC
Number of subjects: 320
Study: 28800501

Group type: EXPERIMENTAL
Intervention: Auditory biofeedback (BF) training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Visual biofeedback (BF) training
Number of subjects: 18
Study: 26329913

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion at a rate of 0.4 μg kg(‐1) h(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at a rate of 0.05 μg kg(‐1) min(‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline infusion (placebo)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion
Number of subjects: 90
Study: 23497495

Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) maneuver (25 cmH2O for 15 seconds) followed by nasal continuous positive airway pressure (NCPAP)
Number of subjects: 276

Group type: COMPARATOR
Intervention: NCPAP alone
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) maneuver
Number of subjects: 276
Study: 21877678

Group type: EXPERIMENTAL
Intervention: Mechanical epithelial debridement
Number of subjects: 33

Group type: COMPARATOR
Intervention: Alcohol-assisted epithelial debridement
Number of subjects: 33
Study: 19464166

Group type: EXPERIMENTAL
Intervention: Capecitabine monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capecitabine and vinorelbine combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral vinorelbine added to capecitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capecitabine-vinorelbine combination
Number of subjects: 0
Study: 17366762

Group type: EXPERIMENTAL
Intervention: Sealant extension to occlusal ART restorations
Number of subjects: 572

Group type: COMPARATOR
Intervention: Sealant free extensions to occlusal amalgam restorations
Number of subjects: 572
Study: 15070929

Group type: EXPERIMENTAL
Intervention: 15 mCi (131)I
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: 20 mCi (131)I
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: 25 mCi (131)I
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: 30 mCi (131)I
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: 35 mCi (131)I
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: 40 mCi (131)I
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: 45 mCi (131)I
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: 50 mCi (131)I
Number of subjects: 509

Group type: COMPARATOR
Intervention: <25 mCi (131)I
Number of subjects: 509
Study: 11766122

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel
Number of subjects: 31

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 31
Study: 9892889

Group type: EXPERIMENTAL
Intervention: Early postpartum discharge
Number of subjects: 3231

Group type: COMPARATOR
Intervention: Standard discharge (not specified)
Number of subjects: 3231
Study: 7811582

Group type: EXPERIMENTAL
Intervention: Elastomer-coated prosthetic graft (Intervascular)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Knitted double-velour prosthesis (Meadow)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Knitted prosthesis (Bard-USCI)
Number of subjects: 30
Study: 3528055

Group type: EXPERIMENTAL
Intervention: Simultaneous methotrexate-5-fluorouracil chemotherapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: 1-hour sequential methotrexate-5-fluorouracil chemotherapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Radical radiation therapy after chemotherapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Chemotherapy responders treated with radiation
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Chemotherapy nonresponders treated with radiation
Number of subjects: 79
Study: 28432210

Group type: EXPERIMENTAL
Intervention: Complex intervention combining personalised feedback on home air quality, behavioural support and nicotine replacement therapy for temporary abstinence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 0
Study: 26892583

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss and exercise training group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Exercise training group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 25519680

Group type: EXPERIMENTAL
Intervention: PXT3003 high dose (HD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22471133

Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion-medication group (25 cases)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acupuncture-medication group (25 cases)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medication group (30 cases)
Number of subjects: 80
Study: 20441458

Group type: EXPERIMENTAL
Intervention: Written emotional expression treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18513915

Group type: EXPERIMENTAL
Intervention: Audiotaped consultations (31 patients)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (27 patients)
Number of subjects: 58
Study: 18679607

Group type: EXPERIMENTAL
Intervention: Lidan Granule (LDG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sodium cholate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 60
Study: 15197500

Group type: EXPERIMENTAL
Intervention: (111)In-DOTATOC
Number of subjects: 5

Group type: COMPARATOR
Intervention: (111)In-DOTATATE
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: (111)In-DOTATOC and (111)In-DOTATATE
Number of subjects: 5
Study: 11389498

Group type: EXPERIMENTAL
Intervention: High-fever scenario (40 degrees C)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Low-fever scenario (38.5 degrees C)
Number of subjects: 98
Study: 9313058

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin administered orally (25 to 50 mg/kg divided into 2 portions) for 14‐42 days
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin administered intravenously (10 to 23 mg/kg injected twice a day) for 14‐18 days
Number of subjects: 139

Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 139

Group type: COMPARATOR
Intervention: Azlocillin
Number of subjects: 139
Study: 8311697

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (30 sessions)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (20 sessions)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (15 sessions)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (10 sessions)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 111
Study: 3743194

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution after induction of anaesthesia
Number of subjects: 44

Group type: COMPARATOR
Intervention: No blood withdrawn (Control)
Number of subjects: 44
Study: 31951913

Group type: EXPERIMENTAL
Intervention: Contraceptive uptake among women with unplanned pregnancies (UP)
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Contraceptive uptake among women with planned pregnancies (PP)
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Contraceptive use at 3-month follow-up for UP group
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Contraceptive use at 3-month follow-up for PP group
Number of subjects: 807
Study: 30732648

Group type: EXPERIMENTAL
Intervention: Var-HSA group (vaccine without human serum albumin)
Number of subjects: 1231

Group type: COMPARATOR
Intervention: Var + HSA group (vaccine with human serum albumin)
Number of subjects: 1231

Group type: EXPERIMENTAL
Intervention: Var-HSA group
Number of subjects: 1231

Group type: COMPARATOR
Intervention: Var + HSA group
Number of subjects: 1231

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1231
Study: 28559014

Group type: EXPERIMENTAL
Intervention: Cisplatin (P)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Cisplatin plus 5FU (PF)
Number of subjects: 113
Study: 25618802

Group type: EXPERIMENTAL
Intervention: Early weightbearing from day 1 of treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-weightbearing for 6 weeks
Number of subjects: 60
Study: 24053153

Group type: EXPERIMENTAL
Intervention: Hexylaminolevulinate (HAL) photodynamic diagnosis (PDD)‐assisted transurethral resection of bladder tumour (TURBT) plus single‐shot intravesical mitomycin C
Number of subjects: 249

Group type: COMPARATOR
Intervention: Conventional white-light‐assisted TURBT plus single‐shot intravesical mitomycin C
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Hexylaminolevulinate (HAL) photodynamic diagnosis (PDD)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Conventional white-light diagnosis
Number of subjects: 249
Study: 21387176

Group type: EXPERIMENTAL
Intervention: +MSS
Number of subjects: 68

Group type: COMPARATOR
Intervention: -MSS
Number of subjects: 68
Study: 19708911

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (2 microg x kg(‐1)) with hyperbaric bupivacaine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl) with hyperbaric bupivacaine
Number of subjects: 54
Study: 17101710

Group type: EXPERIMENTAL
Intervention: 1.2-1.8 mg/kg per day (continued same dose)
Number of subjects: 229

Group type: COMPARATOR
Intervention: 0.5 mg/kg per day (low dose)
Number of subjects: 229